Improved-type human coagulation factor FVII-Fc fusion protein as well as preparation method and application thereof
Disclosed are a recombinant fusion protein of human blood coagulation factor FVII-Fc, preparation method therefor and use thereof. The fusion protein comprises a human FVII, flexible peptide linker, and IgG2 Fc variant sequentially from the N-terminal to the C-terminal. The Fc variant has on lytic a...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed are a recombinant fusion protein of human blood coagulation factor FVII-Fc, preparation method therefor and use thereof. The fusion protein comprises a human FVII, flexible peptide linker, and IgG2 Fc variant sequentially from the N-terminal to the C-terminal. The Fc variant has on lytic activity, and shows minimal Fc-mediated adverse side-effects. The fusion protein has a bioactivity similar to or higher than that of human FVII and a greatly prolonged plasma half-life, thereby improving the pharmacokinetics and pharmaceutical effect. |
---|